Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility

The SARS-CoV-2 pandemic has posed a challenge for correctional facilities worldwide. People in such settings are more vulnerable to severe forms of infection and it is impossible to completely isolate inmates from the outside world. This study aimed to assess the antibody-mediated immune response in...

Descrición completa

Detalles Bibliográficos

Principais autores:	Claudia Maria Trombetta, Serena Marchi, Margherita Leonardi, Angela Stufano, Eleonora Lorusso, Emanuele Montomoli, Nicola Decaro, Nicola Buonvino, Piero Lovreglio
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2022-12-01
Series:	Human Vaccines & Immunotherapeutics
Assuntos:	sars-cov-2 variants mrna vaccine neutralizing antibodies correctional facility correctional officers inmates
Acceso en liña:	http://dx.doi.org/10.1080/21645515.2022.2153537
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!